TL;DR
Get workout gear delivered free with Prime
- Fast, free delivery on millions of items
- Prime Video, Amazon Music and more included
- Member-only deals all year
Craig Hockenberry’s Oct. 28 post recounts treatment for lymphoma, including chemotherapy complications and a gradual return of strength after his final infusions in May. He also describes signs that nerve function in his spine may be improving, while the supplied report does not establish his current cancer status or a medical explanation for that change.
Craig Hockenberry, writing from a hospital bed in a post published October 28, has shared a personal account of lymphoma treatment, severe chemotherapy side effects and a gradual recovery that included possible improvement in longstanding nerve symptoms. His report documents his experience rather than providing a formal medical update on his current cancer status.
Hockenberry said his treatment began with weekly lumbar punctures in which clinicians removed and replaced a small amount of spinal fluid with methotrexate. The six-week course ended in late January, according to his account. He described severe headaches afterward, which he said eased when he lay flat, and said the procedures left him spending many days resting.
He later received infusions of bendamustine and rituximab on a 28-day cycle, finishing his final infusions in May. He reported metallic-tasting food, changes in his diet, fatigue, loss of muscle and a 50-pound weight loss over a couple of months. He said he did not experience nausea or hair loss, though his hair lost its usual body. These details describe his personal response and should not be taken as a prediction of how others will respond to treatment.
Hockenberry also recounted a serious illness in March, after an infusion, when he said he developed pneumonia affecting people with weakened immune systems, his blood oxygen fell below 90%, and his Apple Watch alerted him to an atrial fibrillation episode. He wrote that antibiotics helped him recover and that he chose to continue chemotherapy after his doctor offered the option of skipping the next cycle. He described taking daily walks with walking sticks despite weakness and balance problems.
Treatment Effects and a Possible Change
The account offers a patient’s perspective on the physical demands of lymphoma treatment, including changes in taste and strength, fatigue, weight loss and an infection during chemotherapy. It also shows how complications and recovery can shape day-to-day activity: Hockenberry said even a short walk became difficult at his lowest point, while he gradually increased his distance after treatment ended.
His report may be useful to readers seeking to understand one person’s experience, but it is not clinical guidance or evidence that the same effects occur for all patients. Hockenberry’s account also links a new sensation in his legs to a possible change in his spine; that observation is personal, and the post does not provide a confirmed diagnosis or independent medical assessment explaining it.
Products Worth Considering
BowFlex SelectTech 840 Adjustable Kettlebell
BowFlex Results Series SelectTech 552 Adjustable Dumbbell
Levoit Vital 100S-P Air Purifier with Washable Pre-Filter
As an affiliate, we earn on qualifying purchases.
From Spinal Treatment to Recovery
Hockenberry describes two phases of treatment: a six-week course of lumbar punctures with methotrexate, followed by recurring infusions of bendamustine and rituximab. He said the punctures ended in January and the infusion course ended in May. The post does not specify the date of his lymphoma diagnosis or provide details about its subtype, stage or treatment goals.
Alongside chemotherapy, he said he was dealing with nerve damage and impaired balance that had begun before the lymphoma was discovered. He worried that numbness and tingling would persist. After finishing treatment, he reported that his appetite, stamina and ability to walk improved over time. The post traces these events retrospectively and does not give a full medical record or account of care beyond the experiences he chose to share.
“I’m writing this post from a hospital bed. And I couldn’t be happier.”
— Craig Hockenberry, in his October 28 post
Cancer Status and Nerve Symptoms
The supplied post does not state whether Hockenberry’s lymphoma is in remission, whether further treatment or monitoring is planned, or what clinicians have said about his current prognosis. It also does not confirm the precise cause of his nerve damage or explain whether the new leg sensation is medically verified evidence of nerve repair. Hockenberry presents the connection as a possibility, not a settled finding.
Some details, including the account of pneumonia and the reported atrial fibrillation alert, are described by Hockenberry and are not accompanied in the source material by medical records or comments from his clinicians. His post also does not give a complete account of the infection’s diagnosis, duration or follow-up.
Further Updates From Hockenberry
Hockenberry’s post does not announce a specific next treatment, appointment or publication date for another update. The next public information about his health would depend on what he chooses to share, and readers should not infer a treatment outcome from the account of improved stamina or possible nerve recovery.
For now, the clearest timeline in the report is that he completed infusions in May and described gradual improvement afterward. Any clarification about his lymphoma status, ongoing care or the condition of his spinal nerves remains unreported in the source material.
Key Questions
Who wrote the health update?
Craig Hockenberry wrote the personal account, published on Furbo.org on October 28, 2026.
What chemotherapy did Hockenberry describe?
He said he received infusions of bendamustine and rituximab on a 28-day cycle. He also described an earlier six-week course of lumbar punctures involving methotrexate.
What complications did he report?
Hockenberry described fatigue, muscle loss, altered taste, substantial weight loss and difficulty walking. He also recounted pneumonia and an Apple Watch alert for an atrial fibrillation episode in March. These are details from his personal account.
Did he say his lymphoma is in remission?
No remission status or current cancer assessment appears in the supplied report. It says he finished his infusions in May but does not describe his later test results or prognosis.
Did Hockenberry confirm that his nerve damage has healed?
No. He described a new sensation in his legs that he believed might signal improvement, but the report does not include a confirmed medical explanation or assessment of his nerve symptoms.
Source: furbo.org
